Glucagon-Like Peptide-1(GLP-1) Cardiometabolic Expansion Market Forecast Reveals Where Future Industry Value Will Be Created
GLP-1 cardiometabolic expansion market size reached $59.47 billion in 2026 and is expected to grow to $101.82 billion by 2030 at a 14.4% CAGR. Major players: Eli Lilly and Company, Novo Nordisk A/S.

